Rare disease or rare success: a tale of two genomes
Rare disease or rare success: a tale of two genomes
Rare Disease Day focuses on new approach to finding treatment
Rare Disease Day focuses on new approach to finding treatment
Congenica achieved ISO 27001 and NHS IGT accreditation
Congenica achieved ISO 27001 and NHS IGT accreditation
UCB works with Congenica to support rare disease genomic research
UCB works with Congenica to support rare disease genomic research
Congenica and GenomOncology announce collaborative agreement at AMP
Congenica and GenomOncology announce collaborative agreement at AMP
Rare disease diagnosis available in days not years
Rare disease diagnosis available in days not years
Genomics England announces Congenica as an interpretation partner as it expands industry engagement
Genomics England announces Congenica as an interpretation partner as it expands industry engagement
Congenica awarded £300k Innovate UK grant to unlock stratified medicine, life sciences minister announces
Congenica awarded £300k Innovate UK grant to unlock stratified medicine, life sciences minister announces
Great Ormond Street Hospital and Congenica Announce Partnership to Improve Rare Disease Diagnosis
Great Ormond Street Hospital and Congenica Announce Partnership to Improve Rare Disease Diagnosis
Manchester first to adopt Congenica’s Sapientia technology for clinical service
Manchester first to adopt Congenica’s Sapientia technology for clinical service
Genomics England selects Congenica to provide clinical interpretation services
Genomics England selects Congenica to provide clinical interpretation services
Congenica genome diagnostics company raises £2.2M from Amadeus Capital Partners & Cambridge Innovation Capital
Congenica genome diagnostics company raises £2.2M from Amadeus Capital Partners & Cambridge Innovation Capital